Rothermich Marcus A, Fleisig Glenn S, Lucas Hunter E, Ryan Michael K, Emblom Benton A, Cain E Lyle, Dugas Jeffrey R
American Sports Medicine Institute, Birmingham, Alabama, USA.
Orthop J Sports Med. 2021 Oct 6;9(10):23259671211038320. doi: 10.1177/23259671211038320. eCollection 2021 Oct.
Recent innovative techniques have led to renewed interest in ulnar collateral ligament (UCL) repair. Although early outcome data regarding the clinical outcome of overhead athletes undergoing UCL repair with augmentation have been encouraging, long-term data are still needed to evaluate both the appropriate indications and success rate for this procedure.
To describe and evaluate the acute complications seen in a large cohort of patients who underwent UCL repair with internal brace augmentation at a single institution.
Case series; Level of evidence, 4.
We performed a retrospective chart review of a prospectively collected database, consisting of all patients who underwent UCL repair with internal brace augmentation utilizing a collagen-dipped FiberTape at our institution from August 2013 to January 2020. Patient characteristics, injury setting, side of surgery, and concomitant ulnar nerve transposition procedures were recorded. Early complications of UCL repair (within 6 months of the procedure) were evaluated and characterized as either minor or major, depending on whether the patient required a return to the operating room.
Of the 353 patients who underwent UCL repair at our institution with a minimum of 6-month follow-up, 84.7% (299/353) reported no complications, 11.9% (42/353) reported minor complications-including ulnar nerve paresthesia, postoperative medial elbow pain, and postoperative superficial wound complications-and 3.4% (12/353) required a return to the operating room because of a major complication requiring ulnar nerve exploration/debridement, primary ulnar nerve transposition, or heterotopic ossification excision.
The low major complication rate identified in this study further validates the efficacy of the UCL repair with the internal bracing augmentation technique. Longer term follow-up data are needed to more adequately assess the outcomes and durability of this procedure.
近期的创新技术引发了人们对尺侧副韧带（UCL）修复的新兴趣。尽管关于接受增强修复的过头运动员临床结局的早期数据令人鼓舞，但仍需要长期数据来评估该手术的合适适应症和成功率。
描述并评估在单一机构接受带内支撑增强的UCL修复的大量患者中出现的急性并发症。
病例系列；证据等级，4级。
我们对一个前瞻性收集的数据库进行了回顾性图表审查，该数据库包含2013年8月至2020年1月在我们机构接受使用浸有胶原蛋白的纤维带进行带内支撑增强的UCL修复的所有患者。记录患者特征、损伤情况、手术侧以及伴随的尺神经转位手术。评估UCL修复的早期并发症（手术6个月内），并根据患者是否需要返回手术室将其分为轻微或严重并发症。
在我们机构接受UCL修复且至少随访6个月的353例患者中，84.7%（299/353）报告无并发症，11.9%（42/353）报告有轻微并发症，包括尺神经感觉异常、术后内侧肘部疼痛和术后浅表伤口并发症，3.4%（12/353）因严重并发症需要返回手术室，这些并发症包括尺神经探查/清创、原发性尺神经转位或异位骨化切除。
本研究中确定的低严重并发症发生率进一步证实了带内支撑增强技术进行UCL修复的有效性。需要更长时间的随访数据来更充分地评估该手术的结局和耐久性。
